Position in AMGN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$6,923,734
+$2,683,942 QoQ
Shares Held
19,120
+58.7% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
#681
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HENNESSY ADVISORS INC holds $74,827,284 across 8 Drug Manufacturers - General names. AMGN ranks #6 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
114,850 | $14,758,225 | |
| 2 | JNJ |
Johnson & Johnson
|
49,300 | $12,520,721 | |
| 3 | GILD |
Gilead Sciences, Inc.
|
85,199 | $10,764,041 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
163,850 | $9,441,037 | |
| 5 | PFE |
Pfizer Inc
|
296,113 | $7,130,401 | |
| 6 | AMGN |
Amgen Inc
This page
|
19,120 | $6,923,734 | |
| 7 | ABBV |
AbbVie Inc.
|
27,300 | $6,869,772 | |
| 8 | GSK |
GSK plc
|
122,460 | $6,419,353 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,923,734 | 19,120 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,239,792 | 12,050 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $4,287,761 | 13,100 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | $3,880,250 | 13,750 | Shares | Sole | 2025-10-20 | |
| 2025-06-30 | $3,867,058 | 13,850 | Shares | Sole | 2025-07-21 | |
| 2025-03-31 | $4,268,235 | 13,700 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $3,479,544 | 13,350 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $4,220,951 | 13,100 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $4,155,585 | 13,300 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $3,753,024 | 13,200 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $4,464,310 | 15,500 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $2,499,468 | 9,300 | Shares | Sole | 2023-10-18 | |
| 2023-06-30 | $2,109,190 | 9,500 | Shares | Sole | 2023-07-17 | |
| 2023-03-31 | $2,429,587 | 10,050 | Shares | Sole | 2023-04-14 | |
| 2022-12-31 | $9,126,740 | 34,750 | Shares | Sole | 2023-01-20 | |
| 2022-09-30 | $10,086,650 | 44,750 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $10,863,345 | 44,650 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $10,845,627 | 44,850 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $6,985,318 | 31,050 | Shares | Sole | 2022-01-25 | |
| 2021-09-30 | $4,710,197 | 22,150 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $4,923,750 | 20,200 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $4,739,830 | 19,050 | Shares | Sole | 2021-04-19 | |
| 2020-12-31 | $7,173,504 | 31,200 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $8,336,448 | 32,800 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $7,901,310 | 33,500 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $6,973,912 | 34,400 | Shares | Sole | 2020-04-14 | |
| No filing history on record for this holder in this stock. | ||||||